glp 1 drugs benefits MCT2D GLP-1 drugs calm inflammation beyond

The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer

The current report aims to present an overview of current knowledge on GLP-1 RAs based on pragmatic review of the available clinical evidence

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

A new case series presents a unique paradox where GLP-1 RA therapy improved quality of life and resolved diarrhea in two women with

People are losing 15, 20 percent of their body weight